Switzerland holds a leading position worldwide in the medical technology sector. Medical technology does not make as significant a contribution to the gross domestic product in any other country in the world than it does in Switzerland. Switzerland is also in first place, ahead of Germany and the UK in terms of the percentage of medical technology employees as a portion of the entire working population. Switzerland is an extremely attractive location for research, development, and production in the medical technology sector with first-class research institutions, expertise in precision technologies and a sophisticated healthcare system requiring suitable products.
The productivity of the Swiss Life Sciences industry is unrivalled compared with other top locations such as Boston, Öresund, the San Francisco Bay Area, New York, or Paris. Switzerland also holds a leading position when it comes to capital procurement. It represents by far the most important stock exchange for Life Sciences companies in Europe. Around a third of market capitalization on the SIX Swiss Exchange is attributable to Life Sciences companies.